The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Clifford, David B ^a   Evans, Scott R ^b   Yang, Yijun ^b   Gulick, Roy M ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anxiety; Depression; Hepatitis C virus; HIV; Neurocognitive disorder; Sleep

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; EFAVIRENZ; HEPATITIS C ANTIBODY; PROTEINASE INHIBITOR;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; COGNITION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG USE; EXPLORATORY BEHAVIOR; FEMALE; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOOD; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGY; PHASE 3 CLINICAL TRIAL; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SLEEP; SOCIOECONOMICS; STATISTICAL MODEL; SYMPTOM; UNIVERSITY HOSPITAL; VIRUS DETECTION;

EID: 27944476851     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192072.80572.43     Document Type: Article

References (29)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:41-52.
2. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207.
3. Flamm SL. Chronic hepatitis C virus infection. JAMA 2003; 289:2413-2417.
4. Caudai C, Maimone D, Almi P, Annunziata P, Bastianoni I, Boggiano CA, et al. The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C. Int J Gastroenterol Hepatol 1997; 41:411-412.
5. Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundörfer B. Neurological manifestations of chronic hepatitis C. J Neurol 1999; 246:486-491.
6. Tembl JI, Ferrer JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ. Neurologic complications associated with hepatitis C virus infection. Neurology 1999; 53:861-864.
7. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al., for the GERMIVIC. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine 2000; 79:47-56.
8. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-439.
9. Krause J, Schuler A, Ennen JC, Ahl B, Bokemeyer M, Boeker KHW, et al. Cerebral function in hepatitis C patients with normal liver function. J Hepatol 2001; 34:156.
10. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35:440-446.
11. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358:38-39.
12. von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, Kücükkö ylü S, Köller H, Haslinger BA, et al. Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 2004; 35:131-137.
13. Laskus T, Radkowski M, Wilkinson J, Bednarska A, Nowicki M, Rakela J. Hepatitis C virus replication in the central nervous system. In: 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, 24-28 February 2002 [Abstract no. 649-M].
14. Snider WD, Simpson DM, Nielsen S, Gold JWM, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14:403-418.
15. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19:525-535.
16. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19:517-524.
17. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157:867-876.
18. Maunder RG, Hunter JJ, Feinman SV. Interferon treatment of hepatitis C associated with symptoms of PTSD. Psychosomatics 1998; 39:461-464.
19. Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J Hepatol 1999; 31:152-159.
20. Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA III et al., for the ACTG A5095 Protocol Team. Triple nucleoside analogue vs. efavirenz-containing regimens for the initial treatment of HIV-1 infection: AIDS Clinical Trials Group (ACTG) Study A5095. N Engl J Med 2004; 350:1850-1861.
21. Reitan R. Manual for administration of neuropsychological test batteries for adults and children. Tucson, AZ: Neuropsychological Laboratory; 1979.
22. Wechsler D. Wechsler Adult Intelligence Scale (WAIS-III) - Administration and scoring manual. Third. San Antonio: The Psychological Corporation; 1997.
23. Heaton RK, Grant I, Matthews CG. Comprehensive norms for an expanded Halstead-Reitan Battery: demographic corrections, research findings and clinical applications. Odessa, FL: Psychological Assessment Resources; 1991.
24. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. J Appl Psychol Measure 1977; 1:385-401.
25. Buysse DJ, Reynold CF, Monk TH, Kupfer DF. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193-213.
26. Spielberger CD. State-Trait Anxiety Inventory for Adults (Form Y). Redwood City, CA: Mind Garden, Inc.; 1983.
27. Lezak MD. Neuropsychological assessment. Second. New York: Oxford University Press; 1983.
28. von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, Kücükkö ylü S, Köller H, Haslinger BA, et al. Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 2004; 35:131-137.
29. Johnson ME, Fisher DG, Fenaughty A, Theno SA. Hepatitis C virus and depression in drug users. Am J Gastroenterol 1998; 93:785-789.